Loading…
Myelin positron emission tomography (PET) imaging in multiple sclerosis
The first successful use of amyloid PET tracers specific for β-amyloid plaque detection in humans, was in 2004 (Klunk et al., 2004). [...]2011, white-matter uptake was considered as non-specific binding, when studies indicated special application to MS as a myelin marker (Stankoff et al., 2011). [.....
Saved in:
Published in: | Neural regeneration research 2020-10, Vol.15 (10), p.1842-1843 |
---|---|
Main Author: | |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | The first successful use of amyloid PET tracers specific for β-amyloid plaque detection in humans, was in 2004 (Klunk et al., 2004). [...]2011, white-matter uptake was considered as non-specific binding, when studies indicated special application to MS as a myelin marker (Stankoff et al., 2011). [...]higher efficiency in technique validation to arrive at proof-of-tool propriety becomes a prime necessity. In MS, although several animal models are available, none mimic the human disease completely. [...]choice of the appropriate model is based on research questions: is there progressive demyelination and remyelination; is the demyelinated area in the brain, focal or widespread; is there an inflammatory compound together with myelin changes; is the animal a model of relapsing-remitting (RRMS) or progressive (PMS) MS. [Figure 1] presents11C-PIB PET imaging in various species. |
---|---|
ISSN: | 1673-5374 1876-7958 |
DOI: | 10.4103/1673-5374.280311 |